Umifenovir hydrochloride
Based on 12 publication(s) in Google Scholar
Umifenovir hydrochloride is a potent, orally active broad-spectrum antiviral with activity against a number of enveloped and non-enveloped viruses. Umifenovir hydrochloride is used as an anti-influenza virus agent. Umifenovir hydrochloride could effectively inhibit the fusion of virus with host cells. Umifenovir hydrochloride is an efficient inhibitor of SARS-CoV-2 in vitro. Anti-inflammatory activity.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 99.86%
- CAS. Nr.: 131707-23-8
- Formel: C22H26BrClN2O3S
- Molecular Weight:513.88
-
Speicherung:
4°C, sealed storage, away from moisture
* In solvent : -80°C, 1 year; -20°C, 6 months (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
-
Lösungsmittel & Löslichkeit
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
-
HY-13210
ZanamivirNeuraminidase Inhibitor -
HY-B0338A
Rimantadine hydrochlorideAntiviral Agent -
HY-14768
FavipiravirRNA Polymerase Inhibitor -
HY-109025
Baloxavir marboxilInfluenza A/B Inhibitor -
HY-13318
Oseltamivir acidOseltamivir phosphate Metabolite -
HY-15142
Doxorubicin hydrochlorideTopoisomerase Inhibitor -
HY-17016
Oseltamivir phosphateInfluenza A/B Inhibitor -
HY-13605
CytarabineDNA Synthesis Inhibitor -
HY-B0217
NitazoxanideAnthelmintic Agent -
HY-17015A
PeramivirCyclopentane neuraminidase Inhibitor -
HY-14904
UmifenovirAntiviral Agent -
HY-14904AR
Umifenovir hydrochloride (Standard)Antiviral Agent
Publications Citing Use of MedChemExpress (MCE) Umifenovir hydrochloride
More- Signal Transduct Target Ther. 2021 Apr 24;6(1):165. [Abstract]
- Nucleic Acids Res. 2021 Jan 8;49(D1):D1113-D1121. [Abstract]
- Adv Sci (Weinh). 2025 Oct 6:e10597. [Abstract]
- mBio. 2021 Feb 22;13(1):e0304421. [Abstract]
- J Enzyme Inhib Med Chem. 2025 Dec;40(1):2501743. [Abstract]
- ACS Omega. 2025 Dec 8;10(50):62145-62156. [Abstract]
- Viruses. 2021 Jul 23;13(8):1433. [Abstract]
- Viruses. 2019 Jul 20;11(7):665. [Abstract]
- Brain Res. 2026 Aug 15:1885:150331. [Abstract]
- SSRN. 2024 Jan 26.
- Universidade de São Paulo. 2020 Sep.
- bioRxiv. 2020 Mar.
Biologische Aktivität
Beschreibung
IC50 & Target
Antiviral; Anti-influenza agent
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MDCK | CC50 |
32.92 μM
Compound: Arbidol HCl
|
Cytotoxicity against MDCK cells incubated for 1 hr by MTT assay
Cytotoxicity against MDCK cells incubated for 1 hr by MTT assay
|
[PMID: 35085860] |
In Vitro
Umifenovir hydrochloride exhibits a wide range and potent antiviral activity against a number of viruses including influenza A, B and C viruses, respiratory syncytial virus, adenovirus, parainfluenza type 5 and rhinovirus type 14, avian coronavirus, infectious bronchitis virus and Marek disease virus, hepatitis B virus and hepatitis C virus[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c mice were infected with A/FM/1/47 (H1N1)[2]
-
Dosage:45, 90, and 180 mg/kg
-
Administration:p.o.; daily for 5 days
-
Result:Decreased the transcription of cytokines in murine lung following the IFV A (H1N1) Infection.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS. Nr. 131707-23-8
-
Appearance Solid
-
Molecular Weight 513.88
-
Formel C22H26BrClN2O3S
-
Color White to off-white
-
SMILES
O=C(C1=C(CSC2=CC=CC=C2)N(C)C3=C1C(CN(C)C)=C(O)C(Br)=C3)OCC.[H]Cl
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
4°C, sealed storage, away from moisture
* In solvent : -80°C, 1 year; -20°C, 6 months (sealed storage, away from moisture)
Publications (12)
-
Journal Impact Factor
-
Most Recent
-
Signal Transduct Target Ther
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. [Abstract]2021 Apr 24;6(1):165. PMID: 33895786 -
Nucleic Acids Res
COVID19 Drug Repository: text-mining the literature in search of putative COVID19 therapeutics. [Abstract]2021 Jan 8;49(D1):D1113-D1121. PMID: 33166390 -
Adv Sci (Weinh)
Identification of TPRA1 as a Novel Receptor and Predictive Biomarker for Oncolytic Virus M1. [Abstract]2025 Oct 6:e10597. PMID: 41053536 -
mBio
Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model. [Abstract]2021 Feb 22;13(1):e0304421. PMID: 35100870 -
J Enzyme Inhib Med Chem
Natural product sennoside B disrupts liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein by inhibiting its RNA-binding activity. [Abstract]2025 Dec;40(1):2501743. PMID: 40371698 -
ACS Omega
2025 Dec 8;10(50):62145-62156. PMID: 41476561 -
Viruses
3-Indoleacetonitrile Is Highly Effective in Treating Influenza A Virus Infection In Vitro and In Vivo. [Abstract]2021 Jul 23;13(8):1433. PMID: 34452298 -
Viruses
Generation of a Reassortant Influenza A Subtype H3N2 Virus Expressing Gaussia Luciferase. [Abstract]2019 Jul 20;11(7):665. PMID: 31330768 -
Brain Res
Cajanine alleviates anxiety and fear extinction deficits in female mice exposed to single prolonged stress via the ERβ/NF-κB pathway. [Abstract]2026 Aug 15:1885:150331. PMID: 42009177 -
-
-
Lösungsmittel & Löslichkeit
In Vitro:
DMSO : 25 mg/mL (48.65 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
H2O : < 0.1 mg/mL (insoluble)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months (sealed storage, away from moisture). When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months (sealed storage, away from moisture). When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (4.86 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (4.86 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * In solvent : -80°C, 1 year; -20°C, 6 months (sealed storage, away from moisture)
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Reinheit & Dokumentation
-
Data Sheet (279 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Boriskin YS, et al. Arbidol: a broad-spectrum antiviral compound that blocks viral fusion. Curr Med Chem. 2008;15(10):997-1005. [Content Brief]
[2]. Liu Q, et al. Antiviral and anti-inflammatory activity of arbidol hydrochloride in influenza A (H1N1) virus infection. Acta Pharmacol Sin. 2013;34(8):1075-1083. [Content Brief]
[3]. Wang X, et al. The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro. Cell Discov. 2020;6:28. Published 2020 May 2. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months (sealed storage, away from moisture). When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.9460 mL | 9.7299 mL | 19.4598 mL | 48.6495 mL |
| 5 mM | 0.3892 mL | 1.9460 mL | 3.8920 mL | 9.7299 mL | |
| 10 mM | 0.1946 mL | 0.9730 mL | 1.9460 mL | 4.8649 mL | |
| 15 mM | 0.1297 mL | 0.6487 mL | 1.2973 mL | 3.2433 mL | |
| 20 mM | 0.0973 mL | 0.4865 mL | 0.9730 mL | 2.4325 mL | |
| 25 mM | 0.0778 mL | 0.3892 mL | 0.7784 mL | 1.9460 mL | |
| 30 mM | 0.0649 mL | 0.3243 mL | 0.6487 mL | 1.6216 mL | |
| 40 mM | 0.0486 mL | 0.2432 mL | 0.4865 mL | 1.2162 mL |
Umifenovir hydrochloride Related Classifications
HY-14904A Related Classifications
Powered by Bioz